These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20159945)

  • 1. Long-Term duloxetine treatment normalizes altered brain-derived neurotrophic factor expression in serotonin transporter knockout rats through the modulation of specific neurotrophin isoforms.
    Calabrese F; Molteni R; Cattaneo A; Macchi F; Racagni G; Gennarelli M; Ellenbroek BA; Riva MA
    Mol Pharmacol; 2010 May; 77(5):846-53. PubMed ID: 20159945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein.
    Calabrese F; Molteni R; Maj PF; Cattaneo A; Gennarelli M; Racagni G; Riva MA
    Neuropsychopharmacology; 2007 Nov; 32(11):2351-9. PubMed ID: 17327885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioural and neuroplastic properties of chronic lurasidone treatment in serotonin transporter knockout rats.
    Luoni A; Hulsken S; Cazzaniga G; Racagni G; Homberg JR; Riva MA
    Int J Neuropsychopharmacol; 2013 Jul; 16(6):1319-30. PubMed ID: 23164505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental influence of the serotonin transporter on the expression of npas4 and GABAergic markers: modulation by antidepressant treatment.
    Guidotti G; Calabrese F; Auletta F; Olivier J; Racagni G; Homberg J; Riva MA
    Neuropsychopharmacology; 2012 Feb; 37(3):746-58. PubMed ID: 22012473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BDNF level in the rat prefrontal cortex increases following chronic but not acute treatment with duloxetine, a dual acting inhibitor of noradrenaline and serotonin re-uptake.
    Mannari C; Origlia N; Scatena A; Del Debbio A; Catena M; Dell'agnello G; Barraco A; Giovannini L; Dell'osso L; Domenici L; Piccinni A
    Cell Mol Neurobiol; 2008 May; 28(3):457-68. PubMed ID: 18172756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure to early life stress regulates Bdnf expression in SERT mutant rats in an anatomically selective fashion.
    Calabrese F; van der Doelen RH; Guidotti G; Racagni G; Kozicz T; Homberg JR; Riva MA
    J Neurochem; 2015 Jan; 132(1):146-54. PubMed ID: 25087780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression and modulation of activity-regulated cytoskeletal associated protein (Arc) in serotonin transporter knockout rats.
    Molteni R; Calabrese F; Maj PF; Olivier JD; Racagni G; Ellenbroek BA; Riva MA
    Eur Neuropsychopharmacol; 2009 Dec; 19(12):898-904. PubMed ID: 19576731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of serotonin transporter alters BDNF expression in the rat brain during early postnatal development.
    Calabrese F; Guidotti G; Middelman A; Racagni G; Homberg J; Riva MA
    Mol Neurobiol; 2013 Aug; 48(1):244-56. PubMed ID: 23564488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BDNF Overexpression in the Ventral Hippocampus Promotes Antidepressant- and Anxiolytic-Like Activity in Serotonin Transporter Knockout Rats.
    Diniz DM; Calabrese F; Brivio P; Riva MA; Grandjean J; Homberg JR
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34068707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
    Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic treatment with duloxetine is necessary for an anxiolytic-like response in the mouse zero maze: the role of the serotonin transporter.
    Troelsen KB; Nielsen EØ; Mirza NR
    Psychopharmacology (Berl); 2005 Oct; 181(4):741-50. PubMed ID: 16032412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential BDNF responses of triple versus dual reuptake inhibition in neuronal and astrocytoma cells as well as in rat hippocampus and prefrontal cortex.
    Prickaerts J; De Vry J; Boere J; Kenis G; Quinton MS; Engel S; Melnick L; Schreiber R
    J Mol Neurosci; 2012 Sep; 48(1):167-75. PubMed ID: 22581450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic exposure to imipramine induces a switch from depression-like to mania-like behavior in female serotonin transporter knockout rats: Role of BDNF signaling in the infralimbic cortex.
    Sadighi M; Mai L; Xu Y; Boillot M; Targa G; Mottarlini F; Brambilla P; Gass P; Caffino L; Fumagalli F; Homberg JR
    J Affect Disord; 2024 Apr; 351():128-142. PubMed ID: 38280571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced function of the serotonin transporter is associated with decreased expression of BDNF in rodents as well as in humans.
    Molteni R; Cattaneo A; Calabrese F; Macchi F; Olivier JD; Racagni G; Ellenbroek BA; Gennarelli M; Riva MA
    Neurobiol Dis; 2010 Mar; 37(3):747-55. PubMed ID: 20034565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-dependent effects of escitalopram on brain derived neurotrophic factor (BDNF) and neuroplasticity related targets in the central nervous system of rats.
    Alboni S; Benatti C; Capone G; Corsini D; Caggia F; Tascedda F; Mendlewicz J; Brunello N
    Eur J Pharmacol; 2010 Sep; 643(2-3):180-7. PubMed ID: 20599917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of long-term administration of duloxetine on the function of serotonin and noradrenaline terminals in the rat brain.
    Rueter LE; Kasamo K; de Montigny C; Blier P
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):600-10. PubMed ID: 9686935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased brain-derived neurotrophic factor (BDNF) protein concentrations in mice lacking brain serotonin.
    Kronenberg G; Mosienko V; Gertz K; Alenina N; Hellweg R; Klempin F
    Eur Arch Psychiatry Clin Neurosci; 2016 Apr; 266(3):281-4. PubMed ID: 26100147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of BDNF expression through promoter IV disturbs expression of monoamine genes in the frontal cortex and hippocampus.
    Sakata K; Duke SM
    Neuroscience; 2014 Feb; 260():265-75. PubMed ID: 24345476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress-induced activation of the brainstem Bcl-xL gene expression in rats treated with fluoxetine: correlations with serotonin metabolism and depressive-like behavior.
    Shishkina GT; Kalinina TS; Berezova IV; Dygalo NN
    Neuropharmacology; 2012 Jan; 62(1):177-83. PubMed ID: 21740920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venlafaxine treatment stimulates expression of brain-derived neurotrophic factor protein in frontal cortex and inhibits long-term potentiation in hippocampus.
    Cooke JD; Grover LM; Spangler PR
    Neuroscience; 2009 Sep; 162(4):1411-9. PubMed ID: 19464349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.